
<!doctype html>
<html id="htmlTag" xmlns="http://www.w3.org/1999/xhtml" class="Unknown 0_0 Unknown Unknown  titanDisplay">
    <head>
            
        <link type='text/css' rel='stylesheet' href='/ClientCss/style_eperc.css'></link>
        <meta name="creator" content="Titan CMS" />
        <title id="pageTitle"># 240 Levorphanol</title>
        <META name='DocID' content='107680'>
<META name='Title' content='# 240 Levorphanol'>
<META name='Keywords' content='# 240 Levorphanol'>
<META name='Description' content='Levorphano is similar to methadone with longer duration; an agonist at the mu, kappa, and delta opioids receptors, an NMDA antagonist, and a monoamine reuptake inhibitor of norepinephrine and serotonin; relatively high cost; suited for neuropathic pain. '>
<META name='Abstract' content='Levorphano is similar to methadone with longer duration; an agonist at the mu, kappa, and delta opioids receptors, an NMDA antagonist, and a monoamine reuptake inhibitor of norepinephrine and serotonin; relatively high cost; suited for neuropathic pain. '>
         
        <link rel="alternate+rss" type="application/rss+xml" title="RSS" href="/display/WhatsNew.rss" />
        
        
        <script type="text/javascript" src='/Scripts/titanscripts.js'></script>
        <script type="text/javascript" src="/Scripts/Banner.js"></script>

        <script src='http://www.google.com/recaptcha/api/js/recaptcha_ajax.js' type='text/javascript'></script>
        
        
        <script type="text/javascript" src='/commonScripts/mcwCommon.js'></script>

<script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
<script type="text/javascript">
try {
var pageTracker = _gat._getTracker("UA-11124256-1");
pageTracker._trackPageview();
} catch(err) {}</script>
    </head>
    <body id="bodyTag" class="titanBody" onload="TitanLoad();" onclick="if (window[&#39;TitanClickHandler&#39;]) TitanClickHandler(this, event)">
        <form action="/EPERC/FastFactsIndex/ff_240.htm?" method="post" id="routerForm" name="routerForm" enctype="multipart/form-data">
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" />


<script src="/ScriptResource.axd?d=xFDxeqDolrWHepB5BOa6WusqXFLn3wro2JYAUSW54WCZIM7tlRS9tbqUciiQ66IHFJNcNWN3CVU9VVXPPRcSENg7qOCQHN4cE4-dXQ8bxlvvzOwDdwbXgIu1gG27qPOQ1CQrIgFe_q5BlrAijrvDUgIWykSGToLqgYeMH1AtHUs1&amp;t=ffffffff940d030f" type="text/javascript"></script>
<script src="/display/components/Blocks/Commenting/Support/CommentingAjax.asmx/js" type="text/javascript"></script>
            
            


<div id="mainBody">
    <div id="pageTopArea">
        <div id="MCWLogoContainer">
            <a href='/MCWHome.htm'><img src='/ClientCSS/images/EPERC_logo_mcw.gif' border='0' alt='MCW Home'/></a>
        </div> <!--/MCWLogoContainer -->
        <div id="logoControlContainer">
            <a href='http://www.mcw.edu/display/router.aspx?docid=67983'><img src='/EPERC/HomePageImages/23923_21666_logo_eperc.gif' border='0' alt=''/></a>
        </div> <!--/logoControlContainer -->
        <div id="utilityNavContainer">
            <!--BeginNoIndex--><ul><li class="navFirst"><a href="/EPERC/Calendar">Calendar</a><span>|</span></li><li class="navLast"><a href="http://www.mcw.edu/display/router.aspx?docid=67983">Home</a></li></ul><!--EndNoIndex-->
        </div><!--/utilityNavContainer -->
        <div id="searchBarContainer">     
            <!--BeginNoIndex-->
<input type="text" id="searchTerms" name="searchTerms" onkeydown="DefaultButton(event, document.getElementById('searchGo'))" onfocus="javascript:this.value='';" value="Search EPERC" /> 
       <input type="button" value="Search" id="searchGo" name="searchGo" class="search" onclick="SearchSubmit('/EPERC/Search', document.getElementById('searchTerms'))" /><!--EndNoIndex-->
        </div><!--/searchBarContainer -->
        <div id="topNavContainer">
            <!--BeginNoIndex--><ul><li class="navFirst"><a href="/EPERC/MSPCEResources">MSPCE Resources</a></li><li><a href="/EPERC/Training">Training</a></li><li><a href="/EPERC/WhatsNew">What's New</a></li><li><a href="/EPERC/FastFactsandConcepts" class="current">Fast Facts</a></li><li><a href="/EPERC/AboutEPERC">About EPERC</a></li><li><a href="/EPERC/EducationalMaterials">Ed Materials</a></li><li class="navLast"><a href="/EPERC/EducationalMaterials/Links">Links</a></li></ul><!--EndNoIndex-->
        </div><!--/topNavContainer -->
    </div><!--/pageTopArea -->
    <div id="contentArea">
        <div id="contentContainer">
            <div id="toolContainer">
            	<div id="breadCrumbContainer">
                	<!--BeginNoIndex-->
<ul>
  <li>
    <a href="/EPERC">EPERC</a>
  </li> &gt;
    <li><a href="/EPERC/FastFactsandConcepts">Fast Facts</a></li> &gt;
    <li><a href="/EPERC/FastFactsIndex"> Fast Facts Documents</a></li> &gt;
    <li class="current"># 240 Levorphanol</li></ul>
<!--EndNoIndex-->
            	</div><!--/toolContainer -->
                <div id="pageTools">
                    <!--BeginNoIndex-->
<ul>
  <li class="print">
    <a href="/EPERC/FastFactsIndex/ff_240.htm?PrintPage=yes&amp;logo=logo_eperc.gif" target="_blank">Print</a>
  </li>
  <li class="email">
    <a href="mailto:?subject=Website%20Link&amp;body=http://www.eperc.mcw.edu/EPERC/FastFactsIndex/ff_240.htm">Email</a>
  </li>
</ul>
<!--EndNoIndex-->
                </div><!--/pageTools-->
            </div><!--/toolContainer -->
            <div id="centerZone">
                <div id="titleBarContainer">
                	<h1># 240 Levorphanol</h1>
            	</div><!--/titleBarContainer -->
                <div blockInfo="Freeform CenterZone BlockID1" class="Freeform CenterZone BlockID1"><h4>
	<a href="/FileLibrary/User/jrehm/fastfactpdfs/Concept240.pdf" linktype="4" target="_blank">FAST FACTS AND CONCEPTS #240 PDF</a></h4>
<p>
	<br />
	<b>Author:</b> Jane E Loitman MD</p>
<p>
	<b>Overview </b>Levorphanol, a &ldquo;forgotten&rdquo; potent opioid agonist, has unique attributes <sup>(1).</sup>&nbsp;This <i>Fast Fact </i>summarizes its pharmacology and role in pain management.</p>
<p>
	<b>Pharmacology &nbsp;</b>Levorphanol is a unique opioid, with both similarities to and important differences from methadone (see <i>Fast Facts</i> #<a href="/fastFact/ff_75.htm" linktype="2" target="_self">75</a>, <a href="/fastFact/ff_86.htm" linktype="2" target="_self">86</a>, <a href="/fastFact/ff_171.htm" linktype="2" target="_self">171</a> about methadone pharmacology).</p>
<ul>
	<li>
		Levorphanol&nbsp;is&nbsp;an agonist at the mu, kappa, and delta opioids receptors, an NMDA antagonist, and a monoamine reuptake inhibitor of norepinephrine and serotonin <sup>(10).&nbsp;</sup></li>
	<li>
		Similar to methadone, levorphanol has a long half-life, and an elimination half-life which is longer than its analgesic duration of action (patients can still have significant tissue and serum levels of levorphanol even after its analgesic effect has waned).&nbsp;Levorphanol&rsquo;s analgesic half-life is comparable to methadone&rsquo;s (6-8 hours), however its elimination half-life of ~11 hours is more predictable than methadone&rsquo;s <sup>(9)</sup>.&nbsp;Accumulation and toxicity can occur if levorphanol&rsquo;s dose is increased too quickly, without waiting for steady-state to occur (at ~5 elimination half-lives or 2-3 days).</li>
	<li>
		Drug concentrations peak 30 minutes after parenteral injection and 1 hour after oral doses.&nbsp;</li>
	<li>
		An oral dose undergoes approximately 50% first-pass clearance.</li>
	<li>
		Levorphanol is metabolized via conjugation to a 3-glucuronide; the cytochrome P450 system does not appear to be involved. &nbsp;It has no known active metabolites.&nbsp;Side effects are similar to other opioids. There are no documented studies showing QT interval prolongation or Torsades de Pointes.&nbsp;</li>
</ul>
<p>
	<b>Clinical Use</b><b>s </b>Several properties of levorphanol make it of interest as an analgesic.</p>
<ul>
	<li>
		Similar to methadone, levorphanol&rsquo;s longer duration of action is not affected by crushing, and it can be safely administered down a gastrostomy tube.</li>
	<li>
		Levorphanol lacks the stigma associated with methadone and its use in addiction medicine.</li>
	<li>
		Levorphanol is a strong NMDA receptor antagonist which has generated interest in it as a treatment for neuropathic pain.&nbsp;Limited research has supported its role as an effective treatment for neuropathic pain, allodynia, and hyperalgesia <sup>(2,3,4,5).&nbsp; </sup>Rowbotham demonstrated a dose-response curve with oral levorphanol for patients with neuropathic pain; 9 mg daily was more effective than 3 mg <sup>(2).&nbsp;</sup>As with methadone, levorphanol has not been directly compared with other opioids or adjuvant analgesics for neuropathic pain.</li>
	<li>
		McNulty showed in a recent case series of 31 patients (including hospice patients and chronic non-malignant pain patients) that 74% of patients had improved pain relief when switching to levorphanol in the setting of inadequately controlled pain on other opioids<sup> (6)</sup>.&nbsp;</li>
</ul>
<p>
	<b>Dosing </b>Parenteral levorphanol is twice as potent as the oral formulation.&nbsp;Published oral morphine:oral levorphanol equianalgesic ratios range from 30:4 to 12:1<sup> (4, 6).&nbsp;</sup>The most recent case series looking at switching from other opioids to levorphanol used a staggered morphine:levorphanol ratio <sup>(6)</sup>, similar in concept to switching to methadone (see Table).&nbsp;Available data indicate these ratios are reasonably safe and effective.&nbsp;The medication is dosed every 6 &ndash; 12 hours depending on an individual patient&rsquo;s duration of analgesia.&nbsp;Opioid na&iuml;ve patients can start with 6 mg orally a day, divided. Levorphanol is available in 2 mg tablets and 2 mg/ml or 2 mg/10ml parenteral formulations.&nbsp;</p>
<p>
	<b>Table. Conversions to Levorphanol <sup>(6)</sup>.</b></p>
<table align="center" border="1" cellpadding="5" cellspacing="0" style="width: 90%">
	<tbody>
		<tr>
			<td>
				<strong>Baseline 24 hour Oral Morphine Equivalent</strong></td>
			<td>
				<strong>Morphine:Levorphanol Ratio</strong></td>
		</tr>
		<tr>
			<td>
				<p>
					<b>&lt;100 mg</b></p>
			</td>
			<td>
				<p>
					12:1&nbsp;(e.g. 60 mg PO morphine/24h = 5 mg PO levorphanol/24h)</p>
			</td>
		</tr>
		<tr>
			<td>
				<p>
					<b>100-299 mg</b></p>
			</td>
			<td>
				<p>
					15:1</p>
			</td>
		</tr>
		<tr>
			<td>
				<p>
					<b>300-599 mg</b></p>
			</td>
			<td>
				<p>
					20:1</p>
			</td>
		</tr>
		<tr>
			<td>
				<p>
					<b>600-799 mg</b></p>
			</td>
			<td>
				<p>
					25:1</p>
			</td>
		</tr>
		<tr>
			<td>
				<p>
					<b>&gt;800 mg</b></p>
			</td>
			<td>
				<p>
					No data</p>
			</td>
		</tr>
	</tbody>
</table>
<p>
	&nbsp;</p>
<p>
	<b>Cost &nbsp; </b>Levorphanol is relatively expensive.&nbsp;A 2 mg tablet is roughly 10 times more expensive than an equivalent dose tablet of methadone and 2 times more expensive than an equivalent dose of a sustained-release morphine tablet.&nbsp;</p>
<p>
	<b>Conclusion </b>Levorphanol is a unique opioid analgesic, has pharmacologic properties which may make it particularly suited for patients with neuropathic pain, and recent data suggesting it is a safe and effective opioid in patients having inadequate response to other opioids.&nbsp;</p>
<p>
	<b>References</b><b> </b></p>
<ol>
	<li>
		Prommer E. Levorphanol: the forgotten opioid. Supp Care in Cancer. 2007; 15:259&ndash;264.</li>
	<li>
		Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D: Oral opioid therapy for Chronic Peripheral and Central Neuropathic Pain. N Engl J Med. 2003; 348:1223&ndash;1232.</li>
	<li>
		Foley KM: Opioids and chronic neuropathic pain. N Engl J Med. 2003; 348:1279&ndash;1281.</li>
	<li>
		Hutson PR, Williams KJ. Methadone, buprenorphine and levorphanol: alternatives for treatment of chronic pain a comparison of the unique properties of each drug and clinical advantages and disadvantages of their use.&nbsp;JPSW. 2009; January/February. Available at:&nbsp;<a href="http://www.pswi.org/communications/journal/2009/Methadone%20Buprenorphine%20and%20Levorphanol%20Alternatives%20for%20Treatment%20of%20Chronic%20Pain.pdf">http://www.pswi.org/communications/journal/2009/Methadone%20Buprenorphine%20and%20Levorphanol%20Alternatives%20for%20Treatment%20of%20Chronic%20Pain.pdf</a>.&nbsp;Accessed January 5, 2011.</li>
	<li>
		Schofferman J,&nbsp;Mazanec D. Evidence-informed management of chronic low back pain with opioid analgesics. The Spine Journal. 2008; 8:185&ndash;194.</li>
	<li>
		McNulty J. Can levorphanol be used like methadone for intractable refractory pain? J Pall Med. 2007; 10(2):293-296.</li>
	<li>
		Bonn B, Masimirembwa CM, Castagnoli N. Exploration of catalytic properties of CYP2D6 and CYP3A4 through metabolic studies of levorphanol and levallorphan. <cite>Drug Metab Dispos.</cite> 2010; 38(1):187-199.</li>
	<li>
		Dixon R, Crews T, Inturrisi C, Foley K. &nbsp;Levorphanol: pharmacokinetics and steady-state plasma concentrations in patients with pain. Res Commun Chem Pathol Pharmacol. 1983; 41:3&ndash;17.</li>
	<li>
		Narcotic Analgesics Comparative Review. In: DRUGDEX&reg; System [Internet database]. Greenwood Village, CO: Thomson Healthcare. Updated periodically.</li>
	<li>
		Tive L, Ginsberg K, Pick CG, Pasternak GW. Kappa3 receptors and levorphanol-induced analgesia.&nbsp; Neuropharm. 1992; 31(9):851-856.</li>
	<li>
		American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 6th Ed. Chicago, IL; American Pain Society; 2008.</li>
</ol>
<p>
	<b>Author Affiliation:&nbsp;</b>Washington University School of Medicine, St Louis, MO.</p>
<p>
	<b><i>Fast Facts and Concepts</i></b><b> </b>are edited by Drew A Rosielle MD, Palliative Care Program, University of Minnesota Medical Center &ndash; Fairview Health Services, and are published by the End of Life/Palliative Education Resource Center at the Medical College of Wisconsin. For more information write to: <a href="mailto:drosiel1@fairview.org">drosiel1@fairview.org</a>.&nbsp;More information, as well as the complete set of <i>Fast Facts</i>, are available at EPERC: <a href="http://www.mcw.edu/eperc">http://www.mcw.edu/eperc</a>. Readers can comment on this publication at the <i>Fast Facts and Concepts Discussion Blog</i> (<a href="http://epercfastfacts.blogspot.com/">http://epercfastfacts.blogspot.com</a>).</p>
<p>
	<b>Copyright/Referencing Information</b>: Users are free to download and distribute <i>Fast Facts</i> for educational purposes only. <b>&nbsp;</b>Loitman JE.&nbsp;Levorphanol.&nbsp;<i>Fast Facts and Concepts</i>. April 2011; 240.&nbsp;Available at:&nbsp;<a href="http://www.eperc.mcw.edu/EPERC/FastFactsIndex/ff_240.htm" linktype="3" target="_blank">http://www.eperc.mcw.edu/EPERC/FastFactsIndex/ff_240.htm</a>.</p>
<p>
	<b>Disclaimer:</b> <i>Fast Facts and Concepts</i> provide educational information. This information is not medical advice. Health care providers should exercise their own independent clinical judgment. Some <i>Fast Facts</i> cite the use of a product in a dosage, for an indication, or in a manner other than that recommended in the product labeling. Accordingly, the official prescribing information should be consulted before any such product is used.</p>
<p>
	<b>ACGME Competencies:</b> Medical Knowledge, Patient Care</p>
<p>
	<b>Keyword(s):</b> Pain &ndash; Opioids</p>
</div> 
				
            </div><!--/centerZone -->
            <div id="rightZone">
                
            </div><!--/rightZone -->
        </div><!--/contentContainer -->
    </div><!-- /contentArea -->
	<div id="bottomContainer">
    	<div id="bottomNavContainer">
            <div id="contentFooter">
                
            </div><!--/ contentFooter-->
        	<!--BeginNoIndex--><ul><li class="navFirst"><a href="http://www.mcw.edu/display/router.aspx?docid=67983">Home</a><span>|</span></li><li><a href="/EPERC/AboutEPERC">About EPERC</a><span>|</span></li><li class="navLast"><a href="/EPERC/SiteMap">Site Map</a></li></ul><!--EndNoIndex-->
    	</div><!--/ bottomNavContainer-->
	</div><!--/bottomContainer -->            
</div><!--/mainBody -->
 
            <input type='hidden' id='flowPlayerSettings' baseDir='/display/components/Blocks/Freeform_CK/ckeditor/plugins/titanflowplayer/' js='flowplayer-3.2.11.min.js' swf='flowplayer-3.2.12.swf' pseudo='flowplayer.pseudostreaming-3.2.9.swf'  Modern='flowplayer.controls-3.2.12.swf' Air='flowplayer.controls-air-3.2.12.swf' Tube='flowplayer.controls-tube-3.2.12.swf'/>          
        </form>
    </body>
</html>
